WallStreetZenWallStreetZen

NASDAQ: AMIX
Autonomix Medical Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their AMIX stock forecasts and price targets.

Forecast return on equity

Is AMIX forecast to generate an efficient return?

Company
-221.25%
Industry
28.51%
Market
228.52%
AMIX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AMIX forecast to generate an efficient return on assets?

Company
-179.77%
Industry
13.33%
AMIX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AMIX earnings per share forecast

What is AMIX's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$2.57
Avg 2 year Forecast
-$1.79
Avg 3 year Forecast
-$2.07

AMIX revenue forecast

What is AMIX's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$918.0k

AMIX vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
AMIX$0.85N/AN/A
BMRA$2.34N/AN/A
INBS$0.73N/AN/A
HSCS$2.67$9.00+237.08%Buy
NAOV$4.15N/AN/A
View Top Medical Device Stocks

Autonomix Medical Stock Forecast FAQ

What is AMIX's earnings growth forecast for 2026-2028?

(NASDAQ: AMIX) Autonomix Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 14.32%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.88%.

Autonomix Medical's earnings in 2025 is -$16,691,000.On average, 4 Wall Street analysts forecast AMIX's earnings for 2026 to be -$17,701,440, with the lowest AMIX earnings forecast at -$18,424,538, and the highest AMIX earnings forecast at -$16,703,565. On average, 4 Wall Street analysts forecast AMIX's earnings for 2027 to be -$12,292,667, with the lowest AMIX earnings forecast at -$15,792,461, and the highest AMIX earnings forecast at -$8,387,937.

In 2028, AMIX is forecast to generate -$14,259,493 in earnings, with the lowest earnings forecast at -$13,700,298 and the highest earnings forecast at -$14,678,890.

If you're new to stock investing, here's how to buy Autonomix Medical stock.

What is AMIX's revenue growth forecast for 2026-2028?

(NASDAQ: AMIX) Autonomix Medical's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.13%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.67%.

Autonomix Medical's revenue in 2025 is $0.On average, 4 Wall Street analysts forecast AMIX's revenue for 2026 to be $0, with the lowest AMIX revenue forecast at $0, and the highest AMIX revenue forecast at $0. On average, 4 Wall Street analysts forecast AMIX's revenue for 2027 to be $0, with the lowest AMIX revenue forecast at $0, and the highest AMIX revenue forecast at $0.

In 2028, AMIX is forecast to generate $6,321,943 in revenue, with the lowest revenue forecast at $6,074,024 and the highest revenue forecast at $6,507,882.

What is AMIX's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: AMIX) forecast ROA is -179.77%, which is lower than the forecast US Medical Devices industry average of 13.33%.

What is AMIX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: AMIX) Autonomix Medical's current Earnings Per Share (EPS) is -$4.65. On average, analysts forecast that AMIX's EPS will be -$2.57 for 2026, with the lowest EPS forecast at -$2.68, and the highest EPS forecast at -$2.43. On average, analysts forecast that AMIX's EPS will be -$1.79 for 2027, with the lowest EPS forecast at -$2.29, and the highest EPS forecast at -$1.22. In 2028, AMIX's EPS is forecast to hit -$2.07 (min: -$1.99, max: -$2.13).

What is AMIX's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: AMIX) forecast ROE is -221.25%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.